Imaging

OCT methods are invaluable in the assessment of patients with the condition.

According to company officials,the new image modality provides additional retinal visualization to our customers as they manage their patient’s treatment and ongoing care.

A team of researchers has now developed an approach to gather and compile a great deal of information about organoids and their development. The team applied its approach to the organoids of the human retina, which they derived from stem cells.

Tips to help eye care providers navigate the maze of insurance issues.

This subtype of artificial intelligence technology may have long-range implications for clinical trials.

A team of researchers have found that STOC tomography enables unprecedented views of eye structure.

The ocular biomarkers studied showed poor to moderate accuracy for detecting the 2 disorders.

The procedures may result in temporary pressure spikes later than expected.

Lawrence Whittle, Chief Commercial Officer for Verana Health, explains what the significance of imaging data linked with electronic health record data means for patient outcomes.

According to a study, untested therapies can cause retinal detachment and blindness.

The therapy may offer novel treatment strategy with unique mechanism, modality for patients diagnosed with dry age-related macular degeneration.

On this week's episode of the NeuroOp Guru, Andy Lee, MD, and Elizabeth Fortin, MD, compare the 1.5 Tesla magnet and the 3.0 Tesla magnet for MRI.

The advanced swept-source OCT technology allows visualization of the variations in the normal changes and those associated with aging in the posterior vitreous.

When paired with SD-OCT, the device also can be used to evaluate photoreceptors.

According to researchers, functional assessments and education are critical to an early diagnosis.

According to a new study from New York Eye and Ear Infirmary of Mount Sinai, a new, non-invasive ocular imaging method may be able to detect an early indicator of glaucoma in time to prevent disease progression and vision loss.

Flavoprotein fluorescence could serve as a new biomarker, according to a Mount Sinai study.

Gareth Lema, MD, PhD, discusses an innovative eye stroke program at Mount Sinai Health System that involves collaboration among ophthalmologists, the stroke service, and emergency department physicians.

According to the company, new imaging options presenting opportunity for better outcomes for patients.

Researchers at the University of Strathclyde have developed an affordable device which takes 3D images and could shift the landscape of eye screening and treatment around the world.

The study investigates 3-year intravitreal implant in eyes with active noninfectious posterior uveitis.

The research from eye care nonprofit Orbis International focuses on diabetic retinopathy in Rwanda, where associated vision complications from diabetes are growing.

With clearer imaging and enhanced resolution, the new OCT approach could improve medical diagnostic imaging.

The rare disorder is often a delayed or misdiagnosed condition, resulting in unnecessary referrals and imaging.